National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 59746 [2024-16172]
Download as PDF
<![CDATA[
59746
Federal Register / Vol. 89, No. 141 / Tuesday, July 23, 2024 / Notices
NC 27709–2233, 984–287–3234, balshaw@
niehs.nih.gov.
Any interested person may file
written comments with the committee
by forwarding the statement to the
Contact Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
procedures at https://www.nih.gov/
about-nih/visitor-information/campusaccess-security for entrance into oncampus and off-campus facilities. All
visitor vehicles, including taxicabs,
hotel, and airport shuttles will be
inspected before being allowed on
campus. Visitors attending a meeting on
campus or at an off-campus federal
facility will be asked to show one form
of identification (for example, a
government-issued photo ID, driver’s
license, or passport) and to state the
purpose of their visit.
Information is also available on the
Institute’s/Center’s home page:
www.niehs.nih.gov/dert/c-agenda.htm,
where an agenda and any additional
information for the meeting will be
posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.115, Biometry and Risk
Estimation—Health Risks from
Environmental Exposures; 93.142, NIEHS
Hazardous Waste Worker Health and Safety
Training; 93.143, NIEHS Superfund
Hazardous Substances—Basic Research and
Education; 93.894, Resources and Manpower
Development in the Environmental Health
Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114,
Applied Toxicological Research and Testing,
National Institutes of Health, HHS)
Dated: July 17, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–16091 Filed 7–22–24; 8:45 am]
BILLING CODE 4140–01–P
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; HHS–NIH–CDC–SBIR PHS
2022–1 Phase II: Novel Platforms for Delivery
and/or Expression of HIV Env Immunogens
for HIV Vaccines (Topic 101).
Date: August 20, 2024.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health 5601 Fishers Lane, 3G34 Rockville,
MD 20892 (Video Assisted Meeting).
Contact Person: Vishakha Sharma, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G34, Rockville, MD
20892, 301–761–7036, vishakha.sharma@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: July 18, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–16172 Filed 7–22–24; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
ddrumheller on DSK120RN23PROD with NOTICES1
National Institutes of Health,
National Institutes of Health
SUMMARY:
18:47 Jul 22, 2024
Jkt 262001
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment
Request; Inclusion Enrollment Report
Form (Office of the Director)
AGENCY:
ACTION:
Notice of Listing of Members of the
National Institutes of Health’s Senior
Executive Service 2024 Performance
Review Board (PRB)
ACTION:
VerDate Sep<11>2014
[FR Doc. 2024–16093 Filed 7–22–24; 8:45 am]
HHS.
Notice.
The National Institutes of
Health (NIH) announces the persons
who will serve on the NIH’s Senior
Executive Service 2024 Performance
Review Board.
FOR FURTHER INFORMATION CONTACT: For
further information about the NIH
Performance Review Board, contact Mr.
Kha Nguyen, Director, Division of
Senior and Scientific Executive
Management, Office of Human
Resources, National Institutes of Health,
Building 31, Room 1C31P, Bethesda,
MD 20892. Telephone 301.594.3022 (not
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
National Institutes of Health,
HHS.
National Institutes of Health
AGENCY:
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
Dated: July 15, 2024.
Lawrence Tabak,
Principal Deputy Director, National Institutes
of Health.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
a toll-free number), email kha.nguyen@
nih.gov.
SUPPLEMENTARY INFORMATION: This
action is being taken in accordance with
5 U.S.C. 4314(c)(4), which requires that
members of performance review boards
be appointed in a manner to ensure
consistency, stability, and objectivity in
performance appraisals and requires
that notice of the appointment of an
individual to serve as a member be
published in the Federal Register.
The following persons will serve on
the NIH Performance Review Board,
which oversees the evaluation of
performance appraisals of NIH Senior
Executive Service (SES) members:
Alfred Johnson, Chair
Lawrence Tabak
Michael Lauer
Nina Schor
John Burklow
Glenda Conroy
Lenora Johnson
Rick Phillips
MaryAnn Sofranko
Notice.
In compliance with the
requirement of the Paperwork
Reduction Act of 1995, for opportunity
for public comment on proposed data
collection projects, the National
Institutes of Health (NIH) will publish
periodic summaries of proposed
projects to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 60 days of the date of this
publication.
SUMMARY:
To
obtain a copy of the data collection
plans and instruments, submit
comments in writing, or request more
information on the proposed project,
contact: Ms. Mikia P. Currie, Program
FOR FURTHER INFORMATION CONTACT:
E:\FR\FM\23JYN1.SGM
23JYN1
]]>Agencies
[Federal Register Volume 89, Number 141 (Tuesday, July 23, 2024)]
[Notices]
[Page 59746]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-16172]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The contract proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; HHS-NIH-CDC-SBIR PHS 2022-1 Phase
II: Novel Platforms for Delivery and/or Expression of HIV Env
Immunogens for HIV Vaccines (Topic 101).
Date: August 20, 2024.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health 5601 Fishers Lane, 3G34 Rockville, MD
20892 (Video Assisted Meeting).
Contact Person: Vishakha Sharma, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3G34,
Rockville, MD 20892, 301-761-7036, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: July 18, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-16172 Filed 7-22-24; 8:45 am]
BILLING CODE 4140-01-P
